Search PDMR transactions

Notifier
Name
Erik Kinnman
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Erik Kinnman
Position
VD
Initial notification
Yes
Amendment
No
Details of amendment
Issuer
Name of issuer
NeuroVive Pharmaceutical AB
LEI code
5493005YV22OTMUHZ183
Details of transaction
Type of financial instrument Name ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Trading venue
Share NeuroVive Pharmaceutical AB SE0002575340 Acquisition 44,901 Quantity 1.32 SEK 21/12/2018 NASDAQ STOCKHOLM AB
Share NeuroVive Pharmaceutical AB SE0002575340 Acquisition 73,000 Quantity 1.30 SEK 27/12/2018 NASDAQ STOCKHOLM AB
Aggregation
Name ISIN code Nature of transaction Transaction date Trading venue Volume Weighted average price
NeuroVive Pharmaceutical AB SE0002575340 Acquisition 21/12/2018 NASDAQ STOCKHOLM AB 44,901 (Quantity) 1.32 SEK
NeuroVive Pharmaceutical AB SE0002575340 Acquisition 27/12/2018 NASDAQ STOCKHOLM AB 73,000 (Quantity) 1.30 SEK
<< Back